Anna Berkenblit
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Renal cell carcinoma treatment 18
-
- Renal and related cancers 6
- PI3K/AKT/mTOR signaling in cancer 5
- Heat shock proteins research 3
- Co-authors
- John M. Lambert (1 shared paper)Andrew Strahs (20 shared papers)Mizue Krygowski (12 shared papers)Jay Feingold (7 shared papers)Stephen A. Cannistra (4 shared papers)Janice P. Dutcher (5 shared papers)Jill S. Clancy (4 shared papers)Gary R. Hudes (5 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Gynecologic Oncology (6 papers)Annals of Oncology (3 papers)Seminars in Oncology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesPolandFrance
In The Last Decade
Anna Berkenblit
57 papers receiving 3.3k citations
Anna Berkenblit's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.2k
- Reproductive Medicine 348
- Cancer Research 591
- Pulmonary and Respiratory Medicine 1.2k
- Genetics 355
Countries citing papers authored by Anna Berkenblit
This map shows the geographic impact of Anna Berkenblit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berkenblit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berkenblit more than expected).
Fields of papers citing papers by Anna Berkenblit
This network shows the impact of papers produced by Anna Berkenblit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berkenblit. The network helps show where Anna Berkenblit may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Berkenblit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Hit paper breakdown → | 2009 | 505 |
| 2 | 2018 | 263 | |
| 3 | 2009 | 253 | |
| 4 | 2012 | 235 | |
| 5 | 2009 | 209 | |
| 6 | Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I Hit paper breakdown → | 2021 | 197 |
| 7 | 2013 | 163 | |
| 8 | 2008 | 140 | |
| 9 | 2011 | 114 | |
| 10 | 2017 | 111 | |
| 11 | 2007 | 95 | |
| 12 | 2007 | 89 | |
| 13 | 2011 | 88 | |
| 14 | 2011 | 84 | |
| 15 | Advances in the management of epithelial ovarian cancer. | 2005 | 80 |
| 16 | 2004 | 78 | |
| 17 | 2009 | 75 | |
| 18 | 2012 | 71 | |
| 19 | 2005 | 61 | |
| 20 | 2009 | 47 |
About Anna Berkenblit
Anna Berkenblit is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Reproductive Medicine, having authored 57 papers that have together received 3.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (18 papers), Cancer Genomics and Diagnostics (10 papers), Ovarian cancer diagnosis and treatment (6 papers), Renal and related cancers (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), HER2/EGFR in Cancer Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Heat shock proteins research (3 papers). The work is most often cited by research in Oncology (1.2k citations), Reproductive Medicine (348 citations), Cancer Research (591 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Genetics (355 citations). Anna Berkenblit has collaborated with scholars based in United States, Poland and France. Frequent co-authors include John M. Lambert, Andrew Strahs, Mizue Krygowski, Jay Feingold, Stephen A. Cannistra, Janice P. Dutcher, Jill S. Clancy, Gary R. Hudes, Laurence Moore and Cezary Szczylik. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Seminars in Oncology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.